Business, energy, technology, markets and global industry news from Business News Today

Aletta

PharmaDeviceNews Aletta
Vitestro’s FDA-authorized Aletta autonomous robotic phlebotomy system uses multimodal imaging and robotics to perform diagnostic blood collection with limited hands-on intervention. Representative image.
Features & Analysis

A robot can now draw blood without hands-on intervention. Can Vitestro’s Aletta solve the phlebotomy staffing problem?

Vitestro’s Aletta has become the first standalone autonomous robotic blood-draw device authorized by the FDA. With one trained supervisor permitted to oversee as many as three systems, the technology could address workforce constraints and standardize venipuncture, but throughput, cost, difficult-vein performance and patient acceptance will determine whether robotics actually changes laboratory medicine.

Read More
Vitestro’s Aletta autonomous robotic phlebotomy system has secured United States Food and Drug Administration De Novo marketing authorization, opening a new regulatory pathway for automated diagnostic blood draws and supervised multi-device operation in the United States. Representative image.
Medical Devices & Diagnostics

Vitestro’s Aletta wins FDA De Novo authorization as robotic phlebotomy moves toward US clinics

FDA authorizes Vitestro’s Aletta robotic blood draw device via De Novo. See how its clinical data could reshape outpatient phlebotomy.

Read More